Medical Devices Japan

Japan Climate-Sensitive Disease Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Climate-Sensitive Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Disease, Test, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $198.5 Mn Placeholder estimate
Estimate 2025 $213.8 Mn 6.2% of the global market
Projected 2034 $416.8 Mn 95% Adds $203.0 Mn over 9 forecast years
CAGR 2025–2034 7.7% Faster than 34% of 173 Medical Devices markets here
Key players 5
  • Japan is 6.22% of the global market.
  • In APAC, the largest is China at $287.5 Mn.
  • Fastest growing: India at 10.3% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$203.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Climate-Sensitive Disease Diagnostics Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $198.5 Mn — —
2025 (base) $213.8 Mn +$15.3 Mn —
2026 (forecast) $230.2 Mn +$16.5 Mn +7.7%
2027 (forecast) $248.0 Mn +$17.7 Mn +16%
2028 (forecast) $267.1 Mn +$19.1 Mn +24.9%
2029 (forecast) $287.6 Mn +$20.6 Mn +34.5%
2030 (forecast) $309.8 Mn +$22.1 Mn +44.9%
2031 (forecast) $333.6 Mn +$23.9 Mn +56.1%
2032 (forecast) $359.3 Mn +$25.7 Mn +68.1%
2033 (forecast) $387.0 Mn +$27.7 Mn +81%
2034 (forecast) $416.8 Mn +$29.8 Mn +95%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Climate-Sensitive Disease Diagnostics Market Analysis at a glance
Market size, 2025$213.8 Mn placeholder estimate
Forecast, 2034$416.8 Mn placeholder estimate
Growth (CAGR), 2025–20347.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease and test (see all)
Key playersAbbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V., Molbio Diagnostics (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Climate-Sensitive Disease Diagnostics Market Analysis Executive Summary

Climate-sensitive disease diagnostics detect illnesses spreading with climate change, such as dengue, malaria, cholera and heat illness.

Key segments of the climate-Sensitive Disease Diagnostics market include disease (Dengue, Malaria and Cholera) and test (Rapid Tests and Molecular Tests).

Bar chart: Japan Climate-Sensitive Disease Diagnostics market size, 2024–2034, placeholder estimates. $198.5 Mn in 2024, $213.8 Mn in 2025 and $416.8 Mn in 2034, 7.7% CAGR.
Japan Climate-Sensitive Disease Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Climate-Sensitive Disease Diagnostics Market Dynamics

Market Growth Drivers

More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.

Opportunity

Early warning systems, greener hospitals and climate-resilient supply chains give the climate-Sensitive Disease Diagnostics market strong room to grow.

Market Restraints

Limited dedicated funding, unclear responsibility between agencies and lack of local data hold back the climate-Sensitive Disease Diagnostics market.

Competitive Landscape for Climate-Sensitive Disease Diagnostics Market in Japan

The climate-Sensitive Disease Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Climate-Sensitive Disease Diagnostics Market in Japan

Climate-Sensitive Disease Diagnostics in Japan: rules, payment and health figures

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2] Deaths from air pollution: 12 per 100,000 people in 2019, the latest WHO figure for Japan.⁠[3]

[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[2] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Deaths from air pollution (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how climate-Sensitive Disease Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Climate-Sensitive Disease Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Climate-Sensitive Disease Diagnostics in context

Japan compared

  • Deaths from air pollution: 12 per 100,000 people (2019). World: 104 per 100,000 people (2019). 14th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[3]

[1] World Bank Open Data, Deaths from air pollution (per 100,000 people). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Climate-Sensitive Disease Diagnostics market in Japan?
Placeholder estimate: about $213.8 Mn in 2025, rising to about $416.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Climate-Sensitive Disease Diagnostics market in Japan growing?
Placeholder estimate: about 7.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Climate-Sensitive Disease Diagnostics market report cover?
The report splits the market by disease (Dengue, Malaria, Cholera, Leptospirosis and more) and test (Rapid Tests, Molecular Tests).
Who are the key players in the Climate-Sensitive Disease Diagnostics market?
Key players include Abbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V. and Molbio Diagnostics.
What is driving the Climate-Sensitive Disease Diagnostics market?
More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.
Who regulates Climate-Sensitive Disease Diagnostics in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
What does WHO report for Japan?
Deaths from air pollution: 12 per 100,000 people in 2019, the latest WHO figure. Source: WHO Global Health Observatory, Deaths from air pollution (per 100,000 people). Retrieved 15 Nov 2026.
How many people in Japan are 65 or older?
30.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Climate-Sensitive Disease Diagnostics?
PubMed lists 16 papers on Climate-Sensitive Disease Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on climate and health and infectious diseases

See the topic